A growing number of experimental and clinical studies have demonstrated correlations of CA IX expressed in tumor or stromal cells to aggressive phenotype, resistance to chemo-/radiotherapy and poor cancer prognosis in a spectrum of tumor types [14]. The gene discussed is CA9; the disease is neoplasm.